Physician profile
Robert K Lee
NPI 1881757078
$7,836.62
in general payments reported to CMS, 2019-2025
44 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $446 · 2021: $152 · 2022: $531 · 2023: $1,813 · 2024: $2,087 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929 · Travel and Lodging: $2,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,929.36 |
| Travel and Lodging | $2,618.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,894.15 | 2023-2025 | Prostep, Augment Injectable, Prophecy |
| Treace Medical Concepts, INC. | $1,733.79 | 2019-2024 | |
| Smith+Nephew, INC. | $529.84 | 2019-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Melinta Therapeutics, LLC | $418.04 | 2019-2025 | Kimyrsa |
| Advanced Oxygen Therapy INC. | $378.73 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Abbvie INC. | $241.00 | 2022-2024 | |
| Paratek Pharmaceuticals, INC. | $232.19 | 2020-2025 | Nuzyra |
| Orthofix Medical, INC. | $216.66 | 2024-2025 | Physio-Stim, Tl-Hex Truelok Hexapod System |
| Biotissue Holdings INC. | $170.44 | 2021-2023 | |
| Medela LLC | $141.56 | 2020 | |
| Integra Lifesciences Corporation | $141.21 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Arthrex, INC. | $134.68 | 2019 | |
| Wright Medical Technology, INC. | $125.93 | 2019 | |
| Paragon 28, INC. | $124.77 | 2023 | Portfolio |
| Kci USA, INC. | $119.74 | 2019-2023 | Activ.A.C. |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $114.05 | 2023-2024 | Novosorb Btm |
| Organogenesis INC. | $110.77 | 2020-2023 | Puraply |
| Tei Medical INC. | $90.59 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $86.35 | 2025 | |
| Solventum Corporation | $72.98 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Mimedx Group, INC. | $67.26 | 2025 | |
| Dynasplint Systems INC. | $57.70 | 2022-2025 | Dynasplint |
| Osiris Therapeutics INC. | $55.61 | 2019 | |
| Depuy Synthes Sales INC. | $46.87 | 2025 | Na |
| Bioventus LLC | $44.81 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Saxum Surgical, INC. | $40.80 | 2025 | |
| Polarityte, INC. | $38.96 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.51 | 2019-2025 | Jublia |
| Horizon Therapeutics Plc | $33.50 | 2020 | |
| Bone Support INC. | $33.01 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Next Science LLC | $32.45 | 2023 | Surgx, Blastx, Xperience |
| Zimmer Biomet Holdings, INC. | $31.78 | 2019 | |
| Zyla Life Sciences, INC. | $28.89 | 2019 | |
| Convatec INC. | $26.27 | 2020 | |
| Averitas Pharma INC. | $26.04 | 2023 | Qutenza |
| Reprise Biomedical, INC. | $25.10 | 2024 | Miro3d |
| Curonix LLC | $21.97 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nabriva Therapeutics, Plc | $18.90 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $16.91 | 2019 | |
| Abbott Laboratories | $16.19 | 2023 | Eterna |
| Nevro Corp. | $16.11 | 2022 | |
| Medtronic, INC. | $15.64 | 2024 | Accurian |
| Celularity INC. | $15.00 | 2019 | |
| Tactile Systems Technology INC | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.